Skip to main content

Table 1 Clinico-pathologic parameters of patients involved in the study

From: Epidermal growth factor receptor (EGFR) overexpression in endometrial carcinoma: association with histopathologic parameters

   n (%)
Age(years)   55.76 ± 9.17
EFGR IHC Score   15.39 ± 41.52
Menopausal Status Pre Menopausal 17 (19.1)
Post Menopausal 72 (80.9)
Histological Type endometroid 77 (86.5)
serous 7 (7.9)
clear cell 1 (1.1)
carcinosarcoma 4 (4.5)
Grade Grade I 35 (39.3)
Grade II 38 (42.7)
Grade III 16 (18)
Myometial Invasion Limited To Endometrium 6 (6.7)
Less Than Half Of Myometrium 31 (34.8)
More Than Half Of Myometrium 52 (58.4)
Cervical Invasion Present 23 (25.8)
Absent 66 (74.2)
Adnexal Involvement Present 9 (10.1)
Absent 80 (89.9)
Nodal Status N0 84 (94.4)
N1 4 (4.5)
N2 1 (1.1)
Lymphovascular Invasion Present 6 (6.7)
Absent 83 (93.3)
T Stage T1 62 (69.7)
T2 16 (18)
T3 8 (9)
T4 3 (3.4)
FIGO Stage Stage IA 34 (38.2)
Stage IB 27 (30.3)
Stage II 17 (19.1)
Stage IIIA 7 (7.9)
Stage IIIB 1 (1.1)
Stage IV 3 (3.4)